Cargando…
Increased Carrier Peptide Stability through pH Adjustment Improves Insulin and PTH(1-34) Delivery In Vitro and In Vivo Rather than by Enforced Carrier Peptide-Cargo Complexation
Oral delivery of therapeutic peptides is hampered by their large molecular size and labile nature, thus limiting their permeation across the intestinal epithelium. Promising approaches to overcome the latter include co-administration with carrier peptides. In this study, the cell-penetrating peptide...
Autores principales: | Kristensen, Mie, Guldsmed Diedrichsen, Ragna, Vetri, Valeria, Foderà, Vito, Mørck Nielsen, Hanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589992/ https://www.ncbi.nlm.nih.gov/pubmed/33092079 http://dx.doi.org/10.3390/pharmaceutics12100993 |
Ejemplares similares
-
Applications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein Cargos
por: Kristensen, Mie, et al.
Publicado: (2016) -
Peptide–Membrane Interactions Monitored by
Fluorescence Lifetime Imaging: A Study Case of Transportan 10
por: Anselmo, Sara, et al.
Publicado: (2021) -
Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis
por: Salave, Sagar, et al.
Publicado: (2023) -
DNA–Liposome
Hybrid Carriers for Triggered
Cargo Release
por: Baumann, Kevin N., et al.
Publicado: (2022) -
Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis
por: Pearson, Richard G., et al.
Publicado: (2019)